Pancreatic Cancer Research

ResearcherFondazione IRCCS Istituto Nazionale dei TumoriActive in the last 2 years

Federica Perrone

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4406-8245; OpenAlex author ID A5015740152. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 2

  1. Molecular Characterization and Clinical Relevance of MGMT-Silenced Pancreatic Cancer. Co-author DOI 10.1002/cam4.70393↗
  2. Conventional chemotherapy of advanced pancreatic cancer. Last author DOI 10.2174/138945012800564149↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Federico Nichetti · 1 shared paper, 2024 · strength 0.15
  2. Vincenzo Mazzaferro · 1 shared paper, 2024 · strength 0.15
  3. Sara Pusceddu · 1 shared paper, 2024 · strength 0.15
  4. Giuseppe Leoncini · 1 shared paper, 2024 · strength 0.15
  5. Monica Niger · 1 shared paper, 2024 · strength 0.15
  6. Francesco Giuliani · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.